Zantac being pulled over contamination issue
September 18, 2019 05:23 PM
Zantac is being pulled off the market.
The drug's manufacturer has decided to halt distribution of the antacid until a contamination issue is resolved.
As NewsChannel 13 previously reported, the FDA said some lots of ranitidine were found to contain small amounts of an NDMA, considered to be a human carcinogen.
Patients who wish the switch to another medication should talk to their doctor.
Updated: September 18, 2019 05:23 PM
Created: September 18, 2019 03:05 PM
Copyright 2019 WNYT-TV LLC, a Hubbard Broadcasting Company. All rights reserved